FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Filipcik

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Phenomena

Co-author Network

Publications

TOP 3
Alena Opattova; Martin Cente; Peter Filipcik; Michal Novak
Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
Peter Filipcik; Gabriela Krajciova; Boris Mravec; Michal Novak; Petr Novak; Katarina Ondicova; Richard Kvetnansky
Tau protein phosphorylation in diverse brain areas of normal and CRH deficient mice: up-regulation by stress.
Peter Filipcik; Peter Koson; Juraj Kucerak; Petr Novak; Norbert Zilka; Ondrej Bugos; Michal Novak
First transgenic rat model developing progressive cortical neurofibrillary tangles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Filipcik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alena Opattova; Martin Cente; Peter Filipcik; Michal Novak
Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
Journal of Alzheimer's disease : JAD 2013;33(2):339-48.
2012: Peter Filipcik; Gabriela Krajciova; Boris Mravec; Michal Novak; Petr Novak; Katarina Ondicova; Richard Kvetnansky
Tau protein phosphorylation in diverse brain areas of normal and CRH deficient mice: up-regulation by stress.
Cellular and molecular neurobiology 2012;32(5):837-45.
2012: Peter Filipcik; Peter Koson; Juraj Kucerak; Petr Novak; Norbert Zilka; Ondrej Bugos; Michal Novak
First transgenic rat model developing progressive cortical neurofibrillary tangles.
Neurobiology of aging 2012;33(7):1448-56.
2011: K Krskova; R Olszanecki; Norbert Zilka; Peter Filipcik; L Gajdosechova; R Korbut; Stefan Zorad
Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ).
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2011;62(4):403-10.
2009: Martin Cente; Stanislava Mandakova; Peter Filipcik
Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein.
Cellular and molecular neurobiology 2009;29(6-7):945-9.
2009: Peter Filipcik; Martin Cente; Gabriela Krajciova; Ivo Vanicky; Michal Novak
Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration.
Cellular and molecular neurobiology 2009;29(6-7):895-900.
2009: Martin Cente; Peter Filipcik; Stanislava Mandakova; Norbert Zilka; Gabriela Krajciova; Michal Novak
Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy.
Journal of Alzheimer's disease : JAD 2009;17(4):913-20.
2008: Gabriela Krajciova; Rostislav Skrabana; Peter Filipcik; Michal Novak
Preserving free thiols of intrinsically disordered tau protein without the use of a reducing agent.
Analytical biochemistry 2008;383(2):343-5.
2008: Peter Koson; Norbert Zilka; Andrej Kovac; Branislav Kovacech; Miroslava Korenova; Peter Filipcik; Michal Novak
Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
The European journal of neuroscience 2008;28(2):239-46.
2007: Branislav Kovacech; Eva Kontsekova; Norbert Zilka; Pavol Novak; Rostislav Skrabana; Peter Filipcik; Khalid Iqbal; Michal Novak
A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brain.
FEBS letters 2007;581(4):617-22.
2006: Martin Cente; Peter Filipcik; Miroslava Pevalova; Michal Novak
Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
The European journal of neuroscience 2006;24(4):1085-90.
2006: Norbert Zilka; Peter Filipcik; Peter Koson; Lubica Fialova; Rostislav Skrabana; Monika Zilkova; Gabriela Rolkova; Eva Kontsekova; Michal Novak
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
FEBS letters 2006;580(15):3582-8.
2006: Peter Filipcik; M Cente; Miroslav Ferencik; I Hulin; Michal Novak
The role of oxidative stress in the pathogenesis of Alzheimer's disease.
Bratislavské lekárske listy 2006;107(9-10):384-94.
2006: M Pevalova; Peter Filipcik; Michal Novak; Jesús Avila; Khalid Iqbal
Post-translational modifications of tau protein.
Bratislavské lekárske listy 2006;107(9-10):346-53.
2005: Katarina Soltys; Gabriela Rolkova; Lubica Vechterova; Peter Filipcik; Norbert Zilka; Eva Kontsekova; Michal Novak
First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease.
Neuroreport 2005;16(15):1677-81.
1999: Antonino Cattaneo; Simona Capsoni; Elisa Margotti; M Righi; Eva Kontsekova; P Pavlik; Peter Filipcik; M Novak
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(22):9687-97.